1.Locoregional Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
Sang Youn HWANG ; Ryoung Go KIM ; Cheol Won CHOI ; Sang Bu AHN
Journal of Liver Cancer 2016;16(2):69-81
Hepatocellular carcinoma (HCC) patients with portal vein tumor thrombosis (PVTT) have a extremely poor prognosis. According to the Barcelona Clinic Liver Cancer guideline, sorafenib is a standard therapy in this situation, but many clinicians still select locoregional therapy (LRT) such as transarterial therapy, external beam radiation therapy (EBRT), even surgical resection (SR) or combination of LRTs because the survival improvement by sorafenib is unsatisfactory. Based on recent meta-analysis and prospective study, transarterial chemoembolization (TACE) and transarterial radioembolization seem to be effective and safe therapeutic option that have comparable outcome to sorafenib. Recently large nationwide studies demonstrated that SR can be a potentially curative treatment in selected patients. Hepatic arterial infusion chemotherapy (HAIC) can be also good option, especially in Child class B patients based on small volume prospective studies. Moreover, multidisciplinary strategies based on the combination of LRTs (SR plus TACE, TACE + EBRT, TACE + Sorafenib, HAIC + EBRT etc.) may improve survival of HCC patients with PVTT. Finally we discuss individualized and tailored treatment strategies for different clinical situations.
Carcinoma, Hepatocellular*
;
Child
;
Drug Therapy
;
Humans
;
Liver Neoplasms
;
Portal Vein*
;
Prognosis
;
Prospective Studies
;
Thrombosis*
2.The Operative Treatment of Displaced Intra-articular Calcaneal Fracture with Injectable Calcium Sulfate (MIIG(TM)).
Seong Jun AHN ; Bu Hwan KIM ; Moo Ho SONG ; Seong Ho YOO ; Sang Hyok SEO
Journal of Korean Foot and Ankle Society 2007;11(2):221-225
PURPOSE: To evaluate the clinical results of operative treatment of the intra-articular calcaneal fracture with injectable calcium sulfate (MIIG(TM)). MATERIALS AND METHODS: Between March 2004 and October 2006, a total 19 intra-articular calcaneal fracture (16 patients) with a large bony defect that underwent operative treatment with plate fixation and injectable calcium sulfate (MIIG(TM)) with minimum follow-up of one year following. The mean age at time of surgery was 44.7 years (23 to 54). All of the cases were type 2 and 3 on the basis of Sanders classification. The lateral L shaped approach was used in all cases. Full weight bearing on the affected extremity was regained at an average 10 weeks postoperatively. RESULTS: The mean B?hler angle was improved from 2 degrees (-18.5~12.5 degrees) preoperatively to 23.8 degrees (12~37.5 degrees) and the angle at last follow-up was 22.5 degrees (11.5~37.5 degrees), showing about 0.3 degree decline compared to postoperative B?hler angle. Only two case of whitish leakage of graft material but other complication were none. CONCLUSION: MIIG(TM) augumentation of displaced intra-articular calcaneal fracture with large bone defect seems to bo useful method for initial stabilized and plate fixation.
Calcaneus
;
Calcium Sulfate*
;
Calcium*
;
Classification
;
Extremities
;
Follow-Up Studies
;
Intra-Articular Fractures
;
Transplants
;
Weight-Bearing
3.A Comparison of with and without in the Fixation of Distal Chevron Osteotomies for Hallux Valgus.
Seong Ho YOO ; Bu Whan KIM ; Moo Ho SONG ; Seong Jun AHN ; Sang Hyok SEO
Journal of Korean Foot and Ankle Society 2006;10(2):230-233
PURPOSE: The distal chevron osteotomy has gained popularity for the mild to moderate hallux valgus, but necessity of fixation is controversy. No fixation of distal chevron osteotomy cause instability, but fixation has problem which has pin site infection and irritability, extension of operation time, discomfort of rehabilitation. So, the author was going to analyse and compare with and without in the fixation of distal chevron osteotomy. MATERIALS AND METHODS: Between 2004 and 2005, a total 18 patients (20 feet) following with and without in fixation of distal chevron osteotomies. The fixation group (A) was performed for the treatment of 10 patients (10 feet) and no fixation group (B) was done to 8 patients (10 feet). RESULTS: On group A, the mean first MTP (metatarsophalangeal) angle corrected 17 degrees pre-operatively to average 29 degrees (range; 20-37 degrees) and the mean first IM (intermetatarsal) angle corrected 10 degrees pre-operatively to average 15 degrees (range; 9-18 degrees). On Group B, the mean first MTP angle corrected 16 degrees pre-operatively to average 29 degrees (range; 18-33 degrees) and the mean first IM angle corrected 7 degrees pre-operatively to average 13 degrees (range; 9-16 degrees) (P>0.05). Clinical results, based on AOFAS score showed an improvement in the overall results. CONCLUSIONS: Comparing the clinical and radiographic results of the distal chevron osteotomies no difference in with and without fixation of distal chevron osteotomies.
Hallux Valgus*
;
Hallux*
;
Humans
;
Osteotomy*
;
Rehabilitation
4.Neuroimaging of Hemichorea-Hemiballism.
Sang Hun YI ; Tae Beom AHN ; Seon Hee BU ; Deog Yoon KIM
Journal of the Korean Neurological Association 2007;25(3):318-323
BACKGROUND: Hemichorea-Hemiballism (HCHB) can be caused by various diseases such as cerebrovascular disease, hyperglycemia, tumor, and inflammatory diseases. However, there are a few case studies using functional imaging such as single photon emission computed tomography (SPECT). METHODS: In this study, we included patients with HCHB. The patients with hyperglycemia over 250 mg/dl or high signal intensity on T1 weighted imaging were excluded. Clinical and neuroimaging characteristics of the patients were obtained and analyzed. RESULTS: We included 20 patients (M:F=12:8, mean age=67.1+/-15.3). Sixteen patients were presented with hemiballism and four with hemichorea. Six patients had no structural lesions causing HCHB. Subthalamic nucleus was the causative lesion in 6 patients. Other lesions associated with HCHB were basal ganglia, thalamus, and cortices. In a patient without structural lesion, anti-double stranded DNA antibody was detected. Brain SPECT showed not only perfusion abnormalities in the cases without structural lesions but also additional abnormalities in those with definite lesions. CONCLUSIONS: Various mechanisms were related to the development of HCHB. Functional imaging such as SPECT and immunological work-up is needed to investigate the underlying pathomechanism of HCHB.
Basal Ganglia
;
Brain
;
DNA
;
Dyskinesias
;
Humans
;
Hyperglycemia
;
Neuroimaging*
;
Perfusion
;
Subthalamic Nucleus
;
Thalamus
;
Tomography, Emission-Computed, Single-Photon
5.Symptomatic Lateral Patellar Plica : A Case Report.
Moo Ho SONG ; Bu Hwan KIM ; Seong Jun AHN ; Seoung Ho YOO ; Sang Hyok SEO
The Journal of the Korean Orthopaedic Association 2006;41(6):1052-1055
The plica is a remnant of the synovial folds during the coalescence of three compartments of the knee at 8 weeks of fetal development. The plica are classified according to their corresponding anatomic sites of the knee, such as suprapatellar, medial patellar, infrapatellar and lateral patellar plica. The medial patellar plica is considered to be the one most likely to cause problems and has been well documented in the literature. However, there are very few reports of problems being caused by lateral plica. We encountered one case of pathologic lateral plica that was excised by arthroscopy. We report this case with a review of the relevant literature.
Arthroscopy
;
Fetal Development
;
Knee
6.A Case of Achieving Complete Remission with Combination of Sorafenib and Tegafur in Patients with Hepatocellular Carcinoma with Progression of Disease after Sorafenib Therapy.
Sang Youn HWANG ; Seon Mi LEE ; Jung Woo IM ; Ki Jeong JEON ; Sang Bu AHN ; Jin Young PARK ; Cheol Won CHOI ; Kwang Mo YANG
Journal of Liver Cancer 2017;17(1):88-93
Sorafenib is the only approved targeted agent as the first line systemic therapy for treatment of advanced hepatocellular carcinoma (HCC). However, the improvement of survival duration under 3 months is far from clinical satisfactory and most patients experience disease progression within 6 months after sorafenib therapy. Unfortunately, second line systemic therapy after treatment failure of sorafenib was not established and there were no clear guidelines for salvage treatment modalities. Recently, studies suggests that combination of sorafenib and single cytotoxic agent can be relatively effective and safe strategy that achieves promising rates of local and systemic control in advanced HCC patients. Based on above suggestions, we herein offer our experience of a case achieved complete remission by combination therapy of sorafenib and tegafur in the patient with progressed disease after sorafenib therapy.
Carcinoma, Hepatocellular*
;
Disease Progression
;
Humans
;
Salvage Therapy
;
Tegafur*
;
Treatment Failure
7.A Case of Achieving Complete Remission with Stereotactic Body Radiation Therapy in Patients with Hepatocellular Carcinoma with Macrovascular Invasion after Repeated Transarerial Chemoembolization.
Sang Youn HWANG ; Seon Mi LEE ; Jong Woo IM ; Ki Jeong JEON ; Sang Bu AHN ; Eun Kyeong JI ; Jin Young PARK ; Cheol Won CHOI ; Gwang Mo YANG
Journal of Liver Cancer 2016;16(2):123-128
Transarterial chemoembolization (TACE) is the worldwide procedure performed for patients with various stage hepatoceullar carcinoma (HCC), but is not yet considered as curative treatment because of relatively high local recurrence rate. Moreover, many clinicians frequently experience treatment failure (incomplete necrosis or stage progression etc.) after repeated TACE, but no clear guidelines have been recommended about salvage treatment modalities for this situation. Recently, studies for combination of radiation therapy and TACE for HCC with TACE refractoriness have been tried and reported better therapeutic efficacy. Based on above suggestions, we herein offer our experience of a patient with macrovascular invasion developed after repeated TACE that achieve complete remission by stereotactic body radiation therapy. Further study, maybe regarding a combination of locoregional and systemic therapy, is necessary on how to manage HCC patients with TACE refractoriness.
Carcinoma, Hepatocellular*
;
Humans
;
Necrosis
;
Recurrence
;
Salvage Therapy
;
Treatment Failure
8.Incidence of Patent Foramen Ovale in Ischemic Stroke Patients: A Transcranial Doppler Study.
Dae Il CHANG ; Mi Sook LEE ; Sang Hee CHO ; Seon Hee BU ; Se Hee CHUNG ; Seong Hyuk HUH ; Kang Uk YOON ; Tae Beom AHN ; Sung Sang YOON ; Kyung Cheon CHUNG
Journal of the Korean Neurological Association 2005;23(3):313-317
BACKGROUND: Patent foramen ovale (PFO) is increasingly being recognized in stroke patients. The capability of transcranial Doppler (TCD) to detect a PFO has been established. We studied the frequency of PFO in patients with ischemic stroke. METHODS: Eighty-nine patients with ischemic stroke (62 men, mean age: 56.5) consecutively underwent a contrast-enhanced TCD with monitoring of the bilateral middle cerebral arteries (MCA). The contrast solution, which consisted of 8 ml of normal saline, 1 ml of air, and 0.2 ml of patient's blood, was injected twice during normal breathing and the Valsalva maneuver. High intensity transient signals (HITS) were counted for 30 seconds after the injection. RESULTS: Patent foramen ovale was detected in 19 patients (21%). The mean age was similar in those with (55 years) and those without (57 years) PFO. Patent foramen ovale was more frequent among men (26%) than women (11%). There were no differences in the frequency of PFO among stroke subtypes (large artery atherosclerosis, 18%; small artery occlusion, 27%; cardioembolic, 27%; undetermined cause, 11%). CONCLUSIONS: Patent foramen ovale is common in patients with ischemic stroke of all subtypes.
Arteries
;
Atherosclerosis
;
Female
;
Foramen Ovale, Patent*
;
Humans
;
Incidence*
;
Male
;
Middle Cerebral Artery
;
Respiration
;
Stroke*
;
Valsalva Maneuver
9.A Case of Achieving Partial Remission with Sequential Treatment of Transarterial Chemoemoblization after Transarterial Radioembolization in Old Patient with Hepatocellular Carcinoma with Multiple Metastasis
Sang Youn HWANG ; Seon Mi LEE ; Jung Woo IM ; Ki Jeong JEON ; Sang Bu AHN ; Jin Young PARK
Journal of Liver Cancer 2018;18(2):151-156
The number of older adults with hepatocelluar carcinoma (HCC) has been increasing with longer life expectancy and earlier diagnosis and treatment. However, older patients have lesser function reserve of multiple organ systems, more disability rate. Therefore, the treatment of elderly HCC patients remains a challenge worldwide. Recently, studies suggests that the survival outcome of older patients may be comparable to that of younger patients and active treatment may achieve promising rates of local and systemic control in selected patients. Based on above suggestions, we herein offer our experience of a case achieved partial remission by sequential therapy of transarterial chemoembolization after transarterial radioemoblization in elderly HCC patient with multiple metastasis. Further study, maybe regarding a combination of locoregional and systemic treatment, is necessary on how to manage HCC in elderly patients.
Adult
;
Aged
;
Carcinoma, Hepatocellular
;
Diagnosis
;
Humans
;
Life Expectancy
;
Neoplasm Metastasis
10.Perception of ABO and Rh(D) Blood-type in Korean Volunteer Donors.
Nam Sun CHO ; Ok Yim CHOI ; Young Keun LIM ; Seung Hwan KIM ; Su Kyung RYU ; Byoung Choo BAI ; Hyeong Sik AHN ; Sang In KIM
Korean Journal of Blood Transfusion 1998;9(1):73-83
BACKGROUND: It is important to know one's own exact blood type. While the primary purpose of blood donation is an adequate blood supply, it is also an excellent opportunity for donors to confirm their blood type. Over 5% of the total population in Korea donated bloods in 1997. This study was carried out to investigate the relationship between increased participation in blood drives and an increase in members of the public's knowledge of their own blood type. METHODS: 271,346 blood donors at Dung-Bu Red Cross Blood Center answered to a questionnaire. The discrepancy ratio between perceived and actual ABO blood type was obtained through answerey questionnaire. Another 3,058 answered a more detailed questionnaire to probe their general knowledge of ABO and Rh(D) blood types were analyzed. RESLUTS: The discrepancy ratio between real and perceived ABO blood types was 1% but only 90.7% were confident of their ABO blood type. Only 58.3% were correctly answered to their Rh(D) blood type, and 98.7% of the donors who knew his or her Rh(D) blood type as negative were proved to be Rh(D) positive. The ABO discrepancy ratio was lower in females and it has decreased as blood donations increased (p<0.01). The discrepancy ratio increases with the age of the donor, and respondents over 30 had a higher discrepancy than those under 30 (p<0.01). Knowledge of Rh(D) blood type in transfusion was not well known to the general public. CONCLUSION: The study shows that the discrepancy ratio between real and perceived ABO blood type has decreased as a national blood donation rate has increased. Nevertheless, to increase the public's knowledge of blood type in relation to transfusion, especially to increase awareness of Rh(D) blood type, it is needed to conduct test exactly and to educate the result and general knowledge of blood type and tranfusion to the public.
Blood Donors
;
Surveys and Questionnaires
;
Female
;
Humans
;
Korea
;
Questionnaires
;
Red Cross
;
Tissue Donors*
;
Volunteers*